Return
Benign prostatic hyperplasia (the aging prostate)
DOI:10.1016/S0025-7125(05)70159-0.png)
Abstract
En 中文
This article discusses the prevalence, incidence, and pathophysiology of benign prostatic hyperplasia (BPH) in the aging population. The authors also outline current approaches in the treatment of symptomatic BPH.
Keywords:
OBSTRUCTION SYMPTOMATIC BPH
URINARY-TRACT SYMPTOMS
CONTROLLED TRIAL
ALPHA-BLOCKADE
FINASTERIDE
MULTICENTER
TAMSULOSIN
TERAZOSIN
EFFICACY
PLACEBO
Journal
IF:
4.2
Papers:
2.6K
Citations:
6.6K
Organization
No organization information available

